BrightGene Bio-Medical Technology Co

BrightGene Bio-Medical Technology Co Assets per Share

The Total Assets per Share of BrightGene Bio-Medical Technology Co (688166.SS) as of Oct 18, 2026 is 13.77 CNY. In the previous year, Total Assets per Share was 12.21 CNY — a change of 12.79% (higher).

Assets per Share

13.77CNY

YoY

12.79%

Last updated:

Total Assets per Share of BrightGene Bio-Medical Technology Co is 2025 13.77 CNY. Total Assets per Share of BrightGene Bio-Medical Technology Co was 2024 12.21 CNY. It decreases by 12.79% higher compared to the previous year.

The BrightGene Bio-Medical Technology Co Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
2.08 CNY
Jan 1, 2019
3.36 CNY
Jan 1, 2020
4.32 CNY
Jan 1, 2021
7.02 CNY
Jan 1, 2022
11.02 CNY
Jan 1, 2023
11.89 CNY
Jan 1, 2024
12.21 CNY
Jan 1, 2025
13.77 CNY
The BrightGene Bio-Medical Technology Co Assets per Share history
YEARAssets per ShareYoY
13.77CNY+12.79%
12.21CNY+2.63%
11.89CNY+7.95%
11.02CNY+56.97%
7.02CNY+62.47%
4.32CNY+28.60%
3.36CNY+61.81%
2.08CNY+67.34%
1.24CNY+36.63%
0.91CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BrightGene Bio-Medical Technology Co Stock analysis

What does BrightGene Bio-Medical Technology Co do? BrightGene Bio-Medical Technology Co Ltd, headquartered in Suzhou, China, operates in the Health Care sector, specializing in pharmaceuticals. The company researches, develops, and manufactures biopharmaceuticals, medicines, and special generic active pharmaceutical ingredients (APIs) along with finished dosage forms. It employs 1,128 people and is listed on the stock market since November 8, 2019. Its main products include antifungal, antiviral, and immunosuppressive APIs, as well as generic drugs such as entecavir and posaconazole, serving both domestic and international markets. BrightGene Bio-Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BrightGene Bio-Medical Technology Co stock

Total Assets per Share of BrightGene Bio-Medical Technology Co is 13.77 CNY in 2025.

Total Assets per Share of BrightGene Bio-Medical Technology Co changed from 12.21 CNY to 13.77 CNY, representing a 12.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share BrightGene Bio-Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Other — BrightGene Bio-Medical Technology Co

Shares OutstandingSupply ChainNet Debt per ShareAssets per Share

All Key Metrics — BrightGene Bio-Medical Technology Co